Navigation Links
Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
Date:10/4/2007

SOUTH SAN FRANCISCO, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the grant of employment inducement stock options awards in accordance with NASDAQ Marketplace Rule 4350 to two new non-executive employees.

The inducement stock options cover an aggregate of 48,000 shares of common stock and are classified as non-qualified stock options with an exercise price equal to the fair market value of Sunesis' common stock at the close of the trading day on the grant date. These stock options were approved by the Compensation Committee of Sunesis' Board of Directors. The options have a ten-year term and, subject to the terms and conditions of Sunesis' 2006 Employment Commencement Incentive Plan, vest over four years as follows: 25% of the shares subject to each option will vest on the one year anniversary of the grant date of each option; and the remaining 75% of the shares subject to each option will vest in 36 equal monthly increments during each of the second, third and fourth years thereafter.

Pursuant to NASDAQ Marketplace Rule 4350 (i)(1)(A)(iv), the options were granted on September 28, 2007 under Sunesis' 2006 Employment Commencement Incentive Plan, which Sunesis' Board of Directors adopted to facilitate the granting of stock options as an inducement to new employees to join Sunesis. In accordance with NASDAQ rules, these grants of stock options were made under a stock option plan without stockholder approval. NASDAQ rules require public announcement of option grants made under this type of plan.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of
'/>"/>

SOURCE Sunesis Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... 22, 2014 Cloud+MD Office 2.0 ... interoperable suite of medical software and services, designed ... providers, that produces “Actionable Information” to help Independent ... Systems and Billing Services optimize a wide range ... Quality, Greater Efficiency, Noticeable Cost Reductions and Better ...
(Date:7/22/2014)... For the past nine years, the LIVESTRONG Foundation ... tandem to help thousands of cancer patients and survivors ... help survivors connect to resources dealing with work discrimination ... to include referrals from PAF to LIVESTRONG to help ... emotional, and financial issues that accompany a diagnosis. ...
(Date:7/22/2014)... 22, 2014 Joining Conquer Paralysis Now as ... the next decade is Paralympic silver medalist and quadriplegic Jennifer ... became a quadriplegic from a spinal cord injury in 1998. ... a cure for paralysis. , “People define cure differently,” French ... something else. We have the image in our minds of ...
(Date:7/22/2014)... Hills, CA (PRWEB) July 22, 2014 ... document management and workflow solutions, announced today their Gold ... 28 – 31 at Mandalay Bay Hotel and Casino ... Sage customers, Sage Summit draws thousands interested in taking ... leaders, learn how to solve business problems and educate ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Paralympian Jen French Announced as Conquer Paralysis Now’s First Champion 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3
... that it's never too late for a person to start ... ,The researchers particularly taking into consideration the people who ... the exercise need not be of any strenuous nature but ... Dr Dietrich Rothenbacher, an epidemiologist at the University of Heidelberg ...
... variations on how hospitals spend for meals for their ... are spending four times the amounts spent by others.// ... average of ?61 on patients' meals per week as ... to The Scotsman newspaper, there are huge variations reported. ...
... be successfully located with or in pediatric practices, ... Medical Center and the N.C. Chapter of the ... journal Clinical Pediatrics, the researchers said, “With the ... mental health disorders in primary health care settings, ...
... therapy, when used to treat patients who are in ... chances of survival//, say researchers at Rhode Island ... patients over seven years, the median survival rate at ... to 42 months when thermal ablation was followed by ...
... his colleagues working in the laboratory of Dr. Stanley ... that controls// the sensitivity of human cancer cells to ... of research striving towards increased effectiveness of ... in advance of its scheduled August 1 publication date ...
... devised a chip that can be implanted into a patient's arm, ... medical personnel to easily get hold of patients' medical data. , ... have launched the program to test this product, which will go ... ,The chip can be interpreted with the ...
Cached Medicine News:Health News:Exercise Activities Helps To Avoid Heart Ailment 2Health News:Mental Health Providers Can Be Successfully Located With Pediatricians 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 3
(Date:7/21/2014)... Israel , July 21, 2014 ... "Integrity"), developer of the GlucoTrack ® model ... that it has entered, through its wholly-owned subsidiary, ... Wistron Corp, the manufacturing arm of Acer Inc.  ... manufacture and service (on a non-exclusive basis) the ...
(Date:7/21/2014)... JOLLA, Calif. , July 21, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that the U.S. Food & Drug Administration (FDA) ... single stranded, chemically modified oligonucleotide that binds to ... a therapeutic for the treatment of Alport syndrome, ...
(Date:7/21/2014)... DIEGO , July 21, 2014  An International ... a redesign of its iCH CPAP device, Taiwanese device ... humidification. ResMed (NYSE: RMD ) is the ... for the treatment of sleep-disordered breathing. ... improving designs to reach new levels of comfort, performance ...
Breaking Medicine Technology:Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2
... OSLO, Norway, October 31, 2011 Oslo ... oncology. The true strength of the Norwegian cluster lies ... than the ones available to cancer patients today. ... cluster within the field of oncology, dedicated to accelerating ...
... Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and ... (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee ... 01 Blood Glucose Meters as the first and second ... of service as noted by the Uniform Formulary Beneficiary ...
Cached Medicine Technology:Expanding Norwegian Cluster of Excellence Dedicated to Oncology 2Expanding Norwegian Cluster of Excellence Dedicated to Oncology 3ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary. 2
... Shepard Clear Corneal Diamond Knife is a ... Dennis Shepard of Santa Maria, California. This ... Shepard's need for a quality instrument that ... Corneal Surgical technique. Through professional collaboration between ...
The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology....
... Software is a new approach to practice management, ... face in todays healthcare market. OPIE was created ... who work exclusively in this field, so it ... functional and easy-to-use than anything else available. If ...
... The DioLite 532 laser is ... and pigmented skin lesions such as ... port wine stains, lentigines, dermatosis papulosis ... technology offers unsurpassed reliability, a selection ...
Medicine Products: